Green LifeScience Co

Green LifeScience Co Receivables

The Accounts Receivable of Green LifeScience Co (114450.KQ) as of Oct 27, 2026 is 5.02 B KRW. In the previous year, Accounts Receivable was 1.46 B KRW — a change of 243.80% (higher).

Receivables

5.02 BKRW

YoY

243.80%

Last updated:

Accounts Receivable of Green LifeScience Co is 2024 5.02 B KRW. Accounts Receivable of Green LifeScience Co was 2023 1.46 B KRW. It decreases by 243.80% higher compared to the previous year.

The Green LifeScience Co Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2017
9.12 B KRW
Jan 1, 2018
3.23 B KRW
Jan 1, 2019
5.55 B KRW
Jan 1, 2020
1.87 B KRW
Jan 1, 2021
3.56 B KRW
Jan 1, 2022
2.61 B KRW
Jan 1, 2023
1.46 B KRW
Jan 1, 2024
5.02 B KRW
The Green LifeScience Co Receivables history
YEARReceivablesYoY
5.02 BKRW+243.80%
1.46 BKRW-44.16%
2.61 BKRW-26.60%
3.56 BKRW+90.63%
1.87 BKRW-66.35%
5.55 BKRW+72.12%
3.23 BKRW-64.63%
9.12 BKRW+8.82%
8.38 BKRW+12.52%
7.45 BKRW+75.60%
4.24 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Green LifeScience Co Stock analysis

What does Green LifeScience Co do? Green LifeScience Co Ltd produces and sells pharmaceutical and agricultural raw materials and intermediates, including AMZ for crop protection, TAZD as a herbicide intermediate, D003M and T003M for artificial marble additives, and PM04 as a pharmaceutical intermediate. The company distributes its products domestically and to international markets such as Japan, the United States, and Europe, where customers purchase these materials for agricultural and pharmaceutical applications. The firm also offers antibiotics as part of its product portfolio, targeting both domestic and overseas buyers seeking specialized chemical compounds. Green LifeScience Co Ltd generates revenue through the sale of its chemical products to customers in the agricultural and pharmaceutical sectors, with key markets including Japan, the United States, and European countries. The company’s product line caters to the needs of manufacturers requiring raw materials for crop protection, herbicides, and pharmaceutical production. Its domestic and international distribution channels support consistent sales across these segments, leveraging established relationships with buyers in the chemical supply chain. The company's offerings include specific chemical compounds like AMZ, TAZD, D003M, T003M, and PM04, which are sold to customers who integrate them into larger production processes. These products are used in the creation of crop protection materials, herbicides, artificial marble, and pharmaceuticals, serving both local and global markets. Antibiotics are also part of the sales mix, contributing to the firm’s revenue from chemical intermediates and raw materials. Green LifeScience Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Green LifeScience Co stock

Accounts Receivable of Green LifeScience Co is 5.02 B KRW in 2024.

Accounts Receivable of Green LifeScience Co changed from 1.46 B KRW to 5.02 B KRW, representing a 243.80% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Receivable Green LifeScience Co since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's Green LifeScience Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Green LifeScience Co

All Key Metrics — Green LifeScience Co